SIC
PRAH

Salem Investment Counselors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Salem Investment Counselors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,840
Closed -$316K – 726
2019
Q4 		$316K Hold
2,840
– – 0.03% 218
2019
Q3 		$282K Buy
2,840
+60
+2% +$5.96K 0.03% 219
2019
Q2 		$276K Sell
2,780
-790
-22% -$75.4K 0.03% 229
2019
Q1 		$393K Buy
3,570
+730
+26% +$76.3K 0.04% 168
2018
Q4 		$261K Sell
2,840
-730
-20% -$73.9K 0.03% 172
2018
Q3 		$393K Sell
3,570
-710
-17% -$73.9K 0.04% 168
2018
Q2 		$400K Buy
4,280
+40
+0.9% +$3.44K 0.04% 164
2018
Q1 		$348K Hold
4,240
– – 0.04% 172
2017
Q4 		$386K Buy
4,240
+90
+2% +$7.49K 0.04% 172
2017
Q3 		$315K Buy
+4,150
New +$314K 0.04% 178

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Salem Investment Counselors's PRAH Position: Q1 2020 in Review

Salem Investment Counselors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 2,840 shares — an estimated $316K sold.

Salem Investment Counselors first reported a position in PRAH in Q3 2017 and held it in 10 quarters. The position peaked at $400K in Q2 2018. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Salem Investment Counselors reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Salem Investment Counselors sold 2,840 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $316K.
  • Salem Investment Counselors first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 10 quarters.
  • Salem Investment Counselors's PRA Health Sciences, Inc. position peaked at $400K in Q2 2018.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Salem Investment Counselors's 13F filing for Q1 2020, filed 14 May 2020.